250 related articles for article (PubMed ID: 22800896)
1. Therapeutic effects of dl-3-n-butylphthalide in a transgenic mouse model of amyotrophic lateral sclerosis.
Feng XH; Yuan W; Peng Y; Liu MS; Cui LY
Chin Med J (Engl); 2012 May; 125(10):1760-6. PubMed ID: 22800896
[TBL] [Abstract][Full Text] [Related]
2. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
Feng X; Peng Y; Liu M; Cui L
Neuropharmacology; 2012 Feb; 62(2):1004-10. PubMed ID: 22056419
[TBL] [Abstract][Full Text] [Related]
3. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
4. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
[TBL] [Abstract][Full Text] [Related]
5. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.
Yoo YE; Ko CP
Exp Neurol; 2011 Sep; 231(1):147-59. PubMed ID: 21712032
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
[TBL] [Abstract][Full Text] [Related]
7. Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis.
Fontanilla CV; Wei X; Zhao L; Johnstone B; Pascuzzi RM; Farlow MR; Du Y
Neuroscience; 2012 Mar; 205():185-93. PubMed ID: 22206942
[TBL] [Abstract][Full Text] [Related]
8. Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study.
Marcuzzo S; Zucca I; Mastropietro A; de Rosbo NK; Cavalcante P; Tartari S; Bonanno S; Preite L; Mantegazza R; Bernasconi P
Exp Neurol; 2011 Sep; 231(1):30-7. PubMed ID: 21620832
[TBL] [Abstract][Full Text] [Related]
9. Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model.
Sunyach C; Michaud M; Arnoux T; Bernard-Marissal N; Aebischer J; Latyszenok V; Gouarné C; Raoul C; Pruss RM; Bordet T; Pettmann B
Neuropharmacology; 2012 Jun; 62(7):2346-52. PubMed ID: 22369784
[TBL] [Abstract][Full Text] [Related]
10. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice.
Tanaka K; Okada Y; Kanno T; Otomo A; Yanagisawa Y; Shouguchi-Miyata J; Suga E; Kohiki E; Onoe K; Osuga H; Aoki M; Hadano S; Itoyama Y; Ikeda JE
Exp Neurol; 2008 Jun; 211(2):378-86. PubMed ID: 18423451
[TBL] [Abstract][Full Text] [Related]
11. [Effect of transplantation of wild-type bone marrow stem cells in mouse model of familial amyotrophic lateral sclerosis].
Huang H; Zhang C; Zhao CP; Yao XL; Xi J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):562-6. PubMed ID: 16995314
[TBL] [Abstract][Full Text] [Related]
12. Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice.
Turner BJ; Rembach A; Spark R; Lopes EC; Cheema SS
J Neurosci Res; 2003 Nov; 74(4):605-13. PubMed ID: 14598305
[TBL] [Abstract][Full Text] [Related]
13. R13 preserves motor performance in SOD1
Li X; Chen C; Zhan X; Li B; Zhang Z; Li S; Xie Y; Song X; Shen Y; Liu J; Liu P; Liu GP; Yang X
Theranostics; 2021; 11(15):7294-7307. PubMed ID: 34158851
[TBL] [Abstract][Full Text] [Related]
14. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.
Wang R; Zhang D
Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Zhao Z; Fu J; Li S; Li Z
J Neuroimmune Pharmacol; 2019 Dec; 14(4):688-696. PubMed ID: 31321663
[TBL] [Abstract][Full Text] [Related]
16. Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model.
Park JH; Hong YH; Kim HJ; Kim SM; Kim MJ; Park KS; Sung JJ; Lee KW
Neurosci Lett; 2007 Feb; 413(3):265-9. PubMed ID: 17174029
[TBL] [Abstract][Full Text] [Related]
17. Light therapy and supplementary Riboflavin in the SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis (FALS).
Moges H; Vasconcelos OM; Campbell WW; Borke RC; McCoy JA; Kaczmarczyk L; Feng J; Anders JJ
Lasers Surg Med; 2009 Jan; 41(1):52-9. PubMed ID: 19143012
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of hirsutella sinensis on the disease onset and progression of amyotrophic lateral sclerosis in SOD1
Shang HY; Zhang JJ; Fu ZF; Liu YF; Li S; Chen S; Le WD
CNS Neurosci Ther; 2020 Jan; 26(1):90-100. PubMed ID: 31318169
[TBL] [Abstract][Full Text] [Related]
19. An anthocyanin-enriched extract from strawberries delays disease onset and extends survival in the hSOD1
Winter AN; Ross EK; Wilkins HM; Stankiewicz TR; Wallace T; Miller K; Linseman DA
Nutr Neurosci; 2018 Jul; 21(6):414-426. PubMed ID: 28276271
[TBL] [Abstract][Full Text] [Related]
20. A method comparison in monitoring disease progression of G93A mouse model of ALS.
Zhou C; Zhao CP; Zhang C; Wu GY; Xiong F; Zhang C
Amyotroph Lateral Scler; 2007 Dec; 8(6):366-72. PubMed ID: 17852023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
